News Archive of Burrill Report

ArticleAdded
The June 2012 Issue of The Burrill Report05-18-12
European Private Investment Fundraising Up 80 Percent05-18-12
Military Veterans Support Alternative Fuels05-18-12
Kythera Files to Go Public Under JOBS Act05-18-12
International Doctors' Group Criticizes Gates? Global Vaccines Plan05-18-12
Express Scripts Settles Employee Theft Charges05-18-12
Trial Seeks to Stop Alzheimer's before it Starts05-18-12
Agilent Acquires Dako for $2.2 Billion05-18-12
International Doctor's Group Criticizes Gates? Global Vaccines Plan05-18-12
Osiris Wins Canadian Approval for World's First Stem Cell Drug05-18-12
Approvals of Innovative Drugs by FDA Surpass EU, Canada05-18-12
A Venture Investor Cries Mea Culpa05-18-12
Blech, One-Time "King of Biotech," Pleaded Guilty to Manipulating Stock Prices05-11-12
Gilead's Truvada Gains Support for HIV Prevention05-11-12
Daiichi Sankyo Enters Biosimilars Arena with Coherus BioSciences05-11-12
Groups Weigh in on Biosimilars05-11-12
Vertex's Cystic Fibrosis Considered ?Game-Changer?05-11-12
Bayer Appeals Forced Licensing in India05-11-12
Use of Avastin for Eye Disease Could Save NHS $136 Million Annually05-11-12
User Fee Deal Eased Some Burdens, Exacerbated Others, Report Says05-11-12
GSK Goes Hostile 05-12-12
Keeping Score at the FDA 05-11-12
VCs See Sharp Drop in Biotech Investment 05-04-12
Investor Groups to Help Laid-Off Merck KGaA Employees Form Spin-offs05-04-12
NIH Seeks to Find Uses for Shelved Compounds05-04-12
Piecing Together the Proteome05-04-12
Friction for Pharma Abroad, But Progress Too05-04-12
How to Fix Life Sciences IPOs05-04-12
Hedge Fund Attacks Savient Over Financials05-04-12
Castlight Health Secures another $100 Million in a Series D Financing05-04-12
Protalix Approval a Win for Its Manufacturing Technology05-04-12
Takeda Fails to Win FDA Approval for Diabetes Drug04-26-12
Buyouts Catch Fire in Race for Global Market Share04-26-12
Tackling Oral Cancer with a Smartphone04-27-12
FDA's Woodcock Argues for Clinical Research Makeover04-28-12
Saying 04-27-12
AstraZeneca CEO to Step Down04-27-12
P2P Healthcare and the Portals of Power04-27-12
Takeda Fails to Win FDA Approval for Diabetes Drug Alogliptin as Actos Faces Patent Expiration04-26-12
Saying "No" to an IPO04-27-12
NIH grants $10.5 Million for Genome Explorations04-27-12
Novartis Challenging Avastin Use for Eye Disease in the U.K.04-23-12
AstraZeneca Agrees to Buy Ardea Biosciences for $1.3 Billion04-24-12
FDA Stretches to Go Global04-23-12
NICE Rejects Avastin for Breast Cancer04-20-12
Health IT Deals Hot in Q104-19-12
GlaxoSmithKline Steers toward Innovation04-20-12
Survey: One in Four Americans Had a Gap in Healthcare Coverage in 201104-20-12
The May 2012 Issue of The Burrill Report04-20-12
Generic Drugmakers Score Victory at Supreme Court04-20-12
Endocyte Scores with Merck Partnership04-20-12
Race for All-Oral Treatment for Hep C Leaps Forward04-19-12
Roche Decides Against Extending Offer for Illumina04-20-12
Funding Early-Stage Companies with Radical Technologies04-20-12
Amgen to Buy KAI Pharmaceuticals04-13-12
J&J Fined $1.1 Billion For Deceptive Marketing04-13-12
Takeda Acquires URL Pharma in $800 Million Deal04-13-12
Drug Shortages and the Role of the Middle Man04-13-12
Berwick Says Billions Can Be Saved through Cutting Waste04-13-12
R&D Spending for Drug Giants Drops to $49.5 Billion in 201104-13-12
Mayo Clinic launches whole genome breast cancer study04-13-12
Roche Hints at Negotiating Room in Illumina Bid04-14-12
U.S. Should Tax Medical Services to Fund Public Health, Says IOM04-13-12
What's Ahead for Biotech Stocks 04-13-12
BARDA Cuts Funding for Radiation Poisoning Treatment04-06-12
Covidien Looks to Israel for Novel Medical Devices04-06-12
New Report Finds Prescription Drug Spending Flat04-06-12
US Unveils $200 Million Big Data Initiative 04-06-12
GE Expands Diagnostic Business with SeqWright Buy04-06-12
Predictive Value of Whole Genome Sequencing Questioned04-06-12
Amgen and AstraZeneca to Collaborate on Inflammation Portfolio04-06-12
Following Late-Stage Failure, Spectrum To Buy Allos04-06-12
GAO Sees Gloomy Fiscal Outlook without Health Reform04-06-12
Forging a Launch Pad for Emerging Growth IPOs04-06-12
US Protests India's Compulsory License for Nexavar03-30-12
Nanotech Armor Guards Against Breast Cancer Remission03-30-12
FDA Approves Affymax Anemia Therapy03-30-12
New Guidelines on Taking Life's Measure03-30-12
Bausch & Lomb to Buy Ista Pharmaceuticals03-31-12
Celtic Launches ADC Therapeutics with $50 Million03-31-12
Chelsea Therapeutics? Falls on FDA Rejection of Northera03-30-12
Understanding the Shifting Patent Landscape03-30-12
Merrimack IPO Falls Out the Gate03-30-12
How Free Agents are Reshaping the Life Sciences03-22-12
The April 2012 Issue of The Burrill Report03-27-12
Roche and Illumina Duke It out Ahead of Annual Meeting03-24-12
Groups Seek Congressional Action on Drug Shortages03-23-12
JNJ Faces Flood of Lawsuits for Unauthorized Medical Device03-23-12
MediVector Lands $138.5 Million Defense Contract 03-23-12
Unauthorized Distribution of Medical Device Leads to 550 Lawsuits03-23-12
AstraZeneca and Targacept Won?t Seek Approval for Depression Drug03-23-12
Daily Dose of Aspirin Reduces Risk of Cancer03-23-12
Supreme Court Ruling Creates Uncertainty for Diagnostics Companies03-23-12
Senate Passes IPO On-Ramp Bill03-23-12
Wellcome Trust launches $317 million investment fund03-23-12
Wellcome Trust launches $316 million investment fund03-23-12
Healthcare Reform Gets Its Day in Court 03-22-12
Shire Surprisingly Pulls Biologics License Application03-16-12
Biogen Idec Looks Ahead on MS03-16-12
Asahi Kasei Expands in Healthcare with $2.2 Billion Zoll Medical Buy03-16-12
Pfizer Ends $350 Million Insulin Pact03-16-12
Boston Scientific Connects With Vodafone for Cardiac Monitoring03-16-12
Shire Buys FerroKin BioSciences for $325 Million03-16-12
An iPOPping Result03-16-12
India Orders Bayer to License Nexavar03-16-12
Merck Commits $90 Million to Found Drug Discovery Center03-16-12
California Cigarette Tax Could Ignite Cancer Research03-16-12
The Single Biggest Opportunity to Improve Health Outcomes 03-09-12
Gilead Falls on News of Additional Hep C Patients Relapsing03-09-12
Hospital Quality Reporting Program Had Little Impact on Death Rates03-09-12
Cost of Drugs Rockets Past Inflation, Says AARP03-09-12
J&J Impresses with Prostate Cancer Drug03-09-12
Boston Scientific to Acquire Cameron Health for Up to $1.4B03-09-12
Alzheimer's Costs to Top $200 Billion a Year03-10-12
Novartis Takes Glivec Arguments to India's Supreme Court03-09-12
Working Out at Starbucks03-09-12
Joint Venture Seeks to Bring Medical Innovation to Russia03-09-12
Boston Scientific to Acquire Cameron Health for Up to $1.35B03-09-12
Joint Custody03-02-12
Bribery a Growing Legal Liability for Big Pharma, says Reuters03-01-12
Galapagos Scores with Abbott Deal03-01-12
Shire Inks Antibody Discovery Alliance with arGEN-X03-02-12
NIH Takes Its Genetic Testing Registry Online03-01-12
CMS Tries Text Messaging to Improve Health for New Moms03-02-12
FDA Adds New Warnings to Statin Labels03-02-12
Biogen and Samsung Advance Biosimilars Venture03-01-12
Dainippon Sumitomo to Acquire Boston Biomedical 03-02-12
Court Rules New FDA Labels for Cigarettes Unconstitutional03-02-12
The Long Journey from the Amazon to the FDA03-01-12
Borscht Belt02-24-12
Intent Dissent02-23-12
Hepatitis C Remains A Hot Play02-23-12
Patients Sue U.S. Agencies Over Drug Shortages02-24-12
Coming Together02-24-12
FDA Panel Recommends Approval of New Obesity Drug02-24-12
Pfizer and Hisun Near Joint Venture Pact02-24-12
Myriad Case Heads to Court of Public Opinion02-24-12
A Push for Accelerated Approvals02-23-12
The March 2012 Issue of The Burrill Report02-22-12
Proposed FDA Budget Leans on Industry 02-17-12
Gilead Drops on Poor Clinical Trials Results of Pharmasset Drug02-17-12
Rusnano Invests in Novel Diagnostics02-17-12
Despite Cuts, Big Pharma Says It's Still Overstaffed02-17-12
Amyris Scales Back02-17-12
FDA's 2013 Budget Leans on Industry for Boost02-17-12
Biogen Idec Commits Up to $487.5M to Acquire Stromedix02-17-12
Feds Recoup $4.1 Billion in Healthcare Fraud02-17-12
Will Obama's Budget Hinder Innovation?02-16-12
The Sinews of Safety02-09-12
Obama Administration Boosts Alzheimer's Research Spending02-10-12
FDA Unveils Biosimilars Guidance02-10-12
Medical Device Firms Bring In the Bucks02-10-12
Siemens Seeks Growth in Companion Diagnostics02-10-12
Astex Pharma Plummets after Advisory Panel Rejects the Use of Dacogen for Cancer02-10-12
Can the FDA Get California's Biotech Sector Growing Again?02-10-12
Yesterday's Science Fiction, Tomorrow's Reality02-10-12
U.S. Lagging in Science and Technology Education 02-10-12
Obama Administration Boosts Research Spending on Alzheimer's02-10-12
GSK Boast: Improving R&D Productivity02-10-12
Developing Countries Lead Adoption Rate of Biotech Crops02-10-12
Americans Warming to Healthcare Reform Law02-02-12
E-Prescriptions Could Improve Patient Adherence02-03-12
Drug Supplies and Economics 10102-03-12
Big Pharma Declares War on Neglected Diseases02-03-12
Two Life Sciences IPOs Debut Below Target02-03-12
Medical Device Makers Trade Higher Fees Faster Review Times02-03-12
FDA, Industry Urge Quick Passage of User Fee Renewal02-03-12
Federal Spending on Healthcare to Double by 202202-03-12
AstraZeneca Axes 7,300 Jobs, 12 Percent of Workforce02-03-12
Fixing Drug Development with the Wisdom of Crowds02-04-12
Big Biotech Fuels M&A Activity01-27-12
Hitting the Target01-26-12
Infinity Pharmaceuticals Tanks on Failed Cancer Drug Trial01-27-12
Gates Gives Global Fund $750 Million Boost01-27-12
Novo to Launch Type 1 Diabetes R&D Center01-27-12
The Physician Payment Sunshine Act: More Darkness Than Light01-27-12
Kaiser Connects Patients on the Go01-27-12
Strategic Outsourcing To Buoy European Drug Manufacturers01-27-12
What's Driving Roche's $5.7 Billion Bid for Illumina 01-27-12
US Obesity Rates Hold Steady01-20-12
Sanofi Scientist Pleads Guilty to Thefts01-20-12
Pfizer, Medivation End Development of Alzheimer's Drug01-20-12
Proteus Debuts Smart Pill in the United Kingdom01-20-12
Mobile Health App Revenue Perks Up01-20-12
Renewable Energy Group IPO Prices Well Below Target Range 01-20-12
Can Pharma Cure its Social Anxiety Disorder?01-20-12
Janssen's San Diego Experiment01-20-12
Panel Drafts Audacious Plan to Combat Alzheimer's Disease01-20-12
Proteus Debuts Smart Pill in the United Kindom01-20-12
Russian Scientist Say Siberian Bacteria May Slow Aging01-20-12
Can Pharma Cures Its Social Anxiety Disorder01-20-12
The February 2012 Issue of The Burrill Report01-19-12
Novartis to Ax 2,000 jobs after Tekturna Development Halted01-13-12
Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact01-13-12
Forma Therapeutics Inks Alliance with Janssen Biotech01-13-12
Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion01-12-12
Flagship Ventures Launches $270 Million Fund01-12-12
Drugs in Bugs01-13-12
Cutting Healthcare Spending with Occam's Razor01-13-12
Why Regenerative Medicine Might Fix Healthcare01-12-12
Medtronic Scores Digital Health Victory01-06-12
Smith & Nephew and Essex Woodlands Form Joint Venture01-06-12
Forma Cuts $815 Million Deal with Boehringer to Discover New Cancer Drugs01-05-12
Record Drug Shortages Plagued the Year Gone By01-06-12
Medtronic Launches Wireless Glucometer01-06-12
Biogen Idec and Isis Partner on Rare Spinal Disorder01-06-12
Costs of Off-label Marketing of Anti-Psychotic Grow for J&J01-06-12
Teva Names A New CEO01-06-12
Pharma ? Guide Thyself01-06-12
Biotech Investors Get Their War Face On for JPMorgan01-05-12
Deals for the Week Ending December 30, 201112-30-11
Fundraising in 201112-30-11
Genentech: The Beginnings of Biotech12-30-11
Takeda acquires Intellikine for $310M12-22-11
Even the Insured Forgo Care12-23-11
Ranbaxy will pay $500 million to settle issues with FDA12-23-11
Metamark and Janssen Partner on Cancer12-22-11
Widely-Used Estimate of Costs to Develop Drug May Be Conservative12-22-11
DOJ Recovers Billions in Fraudulent Healthcare Charges12-22-11
Pharma's Incredibly Shrinking R&D Budget12-22-11
Filling the Funding Gap12-22-11
Amgen and Watson Enter Biosimilars Collaboration12-22-11
The January 2012 Issue of The Burrill Report12-20-11
Combining Talents to Fund Early Stage Companies12-16-11
Quintiles Launches China CRO12-16-11
Abbott Licenses Reata Pipeline for $400M12-16-11
Amgen CEO and Research Chief to Step Down12-16-11
AstraZeneca Strikes Pact with UK Medical Research Council12-16-11
SEC Charges Stiefel Labs and its Former CEO with Fraud12-16-11
Congress Axes Rule that Restricted Innovation Funding12-16-11
Healthcare Reform Extends Coverage to 2.5M Young Adults12-16-11
BioSante's "Female Viagra" Fails Late-Stage Trials12-16-11
Venture Investors Grow Grim12-16-11
Merck Outlines $1.5 Billion Commitment to Expand R&D in China12-09-11
Pharmacyclics Scores Big with Janssen Biotech Deal12-09-11
Kessler: Bayer Obscured Risks of Contraceptive12-09-11
UK Government Touts Plans for Boosting Drug Development12-09-11
Nursing Workforce Sees Surge in Young Aged Entrants12-09-11
Samsung and Biogen Idec Form $300 Million Joint Venture12-09-11
Qualcomm Formalizes Wireless Health Fund12-09-11
Sebelius Blocks OTC Sales of Morning After Pill to Adolescents 12-09-11
Diagnostics Deals Heat Up12-08-11
New Bill Designed to Make IPOs Welcoming to Emerging Growth Companies12-01-11
Affymetrix Will Pay $330 Million to Acquire eBioscience12-02-11
Obama Appoints New CMS Chief12-02-11
UK's NICE Nixes Novartis? Lucentis for Diabetic Macular Edema12-02-11
Supreme Court Takes On Drug Rep Pay Case12-02-11
AstraZeneca Adds $100 Million to MedImmune Ventures12-02-11
Senators Question Pfizer's Lipitor Deals 12-02-11
Amgen Issued New Patent on RA Drug Enbrel12-01-11
Why Pfizer Might Have Been Better Off Without Lipitor12-01-11
Portola Brings in Cash to Advance Anticoagulant11-22-11
Regeneron Challenges Genentech's Lucentis 11-23-11
Rich Market Unfolds for Mobile Health in Asia11-22-11
Merck pays $950M to Settle Vioxx Criminal and Civil Settlement11-23-11
CVS Strikes Back at Co-Pay Coupons11-23-11
Will Alnylam's Results Reignite Fervor for RNAi11-23-11
Pharma's R&D Costs Soar as Returns Fall11-22-11
Health Network Kicks Into High Gear11-22-11
Gilead Agrees to Buy Pharmasset for $11 Billion11-22-11
Healthcare Companies Lobby To Avoid Cuts11-22-11
Talking Turkey About Access to Medicines11-22-11
Biotechs Rake in the Cash in Mid-Stage Rounds11-17-11
Doctor Who Faked Drug Research Permanently Debarred11-17-11
Pfizer Cuts Lipitor Deals to Fight Generics11-17-11
The Need for Speed11-17-11
Canada Commits $58 Million to Genomics 11-18-11
FDA Revokes Avastin Approval in Breast Cancer11-18-11
Where have all the VC's Gone?11-17-11
New Survey Finds Care is Often Poorly Coordinated11-17-11
Supreme Court to Review Healthcare Law11-16-11
Geron Dumps Stem Cells for Cancer Focus11-16-11
WuXi Forms $50 Million Venture Fund11-16-11
The December 2011 Issue of The Burrill Report11-14-11
NewLink Genetics Goes Public11-11-11
Amylin and Lilly Part Ways on Byetta11-11-11
Former Shanghai Pharmaceutical Exec Gets Suspended Death Sentence 11-11-11
Suicide Switch 11-11-11
China's Largest Biotech Plans IPO11-10-11
Antibiotic Prescriptions for Kids Extremely Common and Frequently Inappropriate11-10-11
Embracing Risk as We Embrace Benefit11-10-11
The Ultimate Exit Strategy11-10-11
Obama's Healthcare Legislation Ruled Constitutional11-10-11
A Mississippi Victory as the Battle Over Stem Cell Research Rages on 11-10-11
A Novel Approach to Funding a Startup11-04-11
GSK Reaches $3 Billion Settlement with U.S. Over Criminal and Civil Investigations11-04-11
Biggest Market Movers11-04-11
Proposed Indian Pricing Scheme Could Slash Prices on Foreign Drugs11-04-11
Mayo Researchers Look to Exploit Measles to Treat Cancer11-04-11
Sanofi Set to Pass Pfizer as Biggest Drug Company11-04-11
Encouraging Data Sends Medivation Soaring11-04-11
Pfizer's and Teva's Results Point to Shifting Demand11-04-11
Payment Disclosure Rules Still Unclear11-04-11
Seeking to End Drug Shortages11-04-11
What A Growing and Aging World Mean for Healthcare 11-04-11
Biotech's Access to Capital Difficult in Volatile Economic Times10-28-11
Biotie Therapeutics Breaks Off Plans to Buy Newron Pharmaceuticals10-28-11
Targeted Therapeutics Get a Russian Boost10-28-11
Common Asthma Drugs May Boost Health Risk for Children10-27-11
Same Fight, New Ring10-26-11
BGI Establishes West Coast Beachhead with UC Davis Deal10-27-11
Molecular Diagnostics Makers Face Tougher Standards for Payment 10-26-11
Cigna Agrees to Acquire HealthSpring for $3.8 Billion10-26-11
Novartis Trims Workforce to Fit a Changing World10-26-11
Roche Makes Germans an Offer It Hopes They Can?t Refuse10-26-11
Chinese National Pleads Guilty to Espionage10-21-11
Zeltiq's Debut Breaks Life Science IPO Doldrums10-20-11
AMAG Shareholders Reject Acquisition of Allos10-21-11
EU High Court Bans Embryonic Stem Cell Patents10-21-11
Roche Buys Anadys for $230M10-21-11
Abbott to Split into Two Independent Public Companies10-21-11
U.S. Health Care System Scores Poorly on National Scorecard 10-21-11
Virtual Care Center, Venture Funds Support Telehealth Efforts10-21-11
Looking for Reassurance at the BIO Investor Forum10-20-11
DNAnexus Nails $15M Venture Investment from Google and TPG10-16-11
GlycoMimetics Inks Deal with Pfizer for Rare Disease Drug10-13-11
Researchers Correct Sickle Cell Disease in Mice10-14-11
Medical Device Developers Attract Cash10-14-11
NICE Says Cost of Bristol-Myers Melanoma Drug Too High10-13-11
The November 2011 Issue of The Burrill Report10-14-11
Europe Warned on Slow Pace of GM Crop Approvals10-13-11
Bayer Launches $860 Million Joint Venture with Russia's Yunona Holdings10-14-11
Can California Protect a Bright Source of Job Growth10-13-11
Planning for Wild Success10-13-11
Et tu, Pharma?10-06-11
Blame it on the FDA10-06-11
Contract Researcher PPD Goes Private10-06-11
Thriving in the Data Deluge10-07-11
Former Cougar Biotechnology CEO Seeks to Repeat Success with Puma10-07-11
Illumina Falls on Disappointing Sales10-06-11
FDA Outlines Innovation Plan10-06-11
Avastin Loses Insurer Support in California10-06-11
Sing for Your Supper10-06-11
German Law Has Companies Weighing Whether to Sell New Drugs In Europe's Largest Market10-06-11
Commonality Vs. Conflict10-03-11
Oxygen Biotherapeutics Says Former CEO Allegedly Falsified Resume, Abused Post09-30-11
Cleveland BioLabs Enters Into a Joint Venture with Rusnano09-30-11
Teva Acquires Control of Teva-Kowa Joint Venture09-30-11
BARDA Steps Up Awards for Radiation Countermeasures09-30-11
DOJ asks Supreme Court Review of the Affordable Care Act09-30-11
Death Panels, Talk Radio, and Unplugging Grandma09-30-11
Drug Shortage Clipping Clinical Trials09-30-11
Boehringer Jumps Into Biosimilars09-30-11
A Tough Road for Health IT Innovators09-30-11
Pressures on Medtech Forcing New Approaches09-30-11
Biorenewables Makers File to Go Public09-23-11
Hua Medicine Lands $50 Million to Finance Its Biotech Activities09-23-11
Pac Bio Slashes Staff Fearing Slower-Than Expected Adoption Because of the Bad Economy09-23-11
Obesity Drugmakers Gain New Traction with FDA09-23-11
GE Establishes Joint Venture in Russia09-23-11
VA Stops Using Avastin for Eyes, Boosting Prospects for Regeneron Drug09-23-11
Report Says Non-communicable Diseases Pose Threat to Economic Health09-22-11
Deficit Reduction Could Pain Biotech09-22-11
GE Establishes Two Joint Ventures in Russia09-22-11
What Patent Reform Means for Biotech09-22-11
Playing a Video Game Like Life is on the Line09-21-11
NIH Initiatives Boost Biotech09-21-11
Teva Pharmaceuticals Strengthens Its Innovation Pipeline09-15-11
A Sweet Sponge Becomes a Familiar Villain09-15-11
Genzyme Must Ration Cerezyme--Again09-16-11
New $100M Challenge Fund Seeks to Spark Cancer Innovation09-16-11
Global Diabetes Epidemic Continues to Rise09-15-11
Public Misreads the Meaning of FDA Approval09-15-11
Pro Bono Bio Melds East and West09-15-11
Express Scripts-Medco Deal Gets Another Going-Over09-15-11
Patient, Know Thyself09-15-11
Sharing the Responsibility09-15-11
A Sweet Sponge Becomes a Familiar Villian09-15-11
Pushing Policies in a Changed Washington 09-15-11
The October 2011 Issue of The Burrill Report09-14-11
BARDA Funds Bioterror Countermeasures09-09-11
Roche and Evotec Enter Alzheimer's Licensing Pact09-08-11
Aurobindo Pharma Expands into Russia09-08-11
Dendreon to Slash 500 Jobs as Part of Restructuring09-08-11
Excess Weight as Young Adult Predicts Earlier Death 09-09-11
Merck Serono Raises Bet on F-Star09-08-11
Eisai Taps Outside Funding09-08-11
Sanofi Projects Growth Despite Challenges09-08-11
GPhA's New CEO Faces a Range of Challenges09-08-11
U.S. Investment in Health Research Remains Stagnant 09-08-11
MedImmune Sues Abbott Alleging Breach of Contract08-25-11
Sanofi Ventures into Nutraceuticals in India08-25-11
Sequencing Tumors to Target Treatments08-25-11
NIH Awards $25 Million to Leverage Genetics with EHRs08-25-11
Pfizer Wins Approval for New Lung Cancer Drug08-26-11
Personalized Cancer Center Gets $30 Million Kick Start08-25-11
Doctors May Need Extra Convincing on Biosimilars 08-25-11
Digital Health Startups Attract Venture Bucks08-26-11
Pulling Together to Cut Costs 08-26-11
FTC Reviews Impact of Authorized Generics09-02-11
Secondary Financings Dry Up09-02-11
What the Market's Turmoil Means for Biotech Stocks08-26-11
NuPathe Loses Half Its Market Cap after FDA Rejects Pain Patch09-02-11
GI Dynamics completes IPO in Australia09-02-11
Taking Cancer Detection Where It's Needed Most09-02-11
Indian Pharma in the Spotlight09-02-11
FDA and Industry Find Common Ground on New Rules09-02-11
Wild Swings of Market in August Rough Up Life Sciences IPOs09-02-11
A Look at the Surge in FDA Approvals 09-02-11
Dirty Laundry at the Hospital09-02-11
Drug Shortages Need Addressing Now08-18-11
IPO Class of 2011 Takes Drubbing08-13-11
Startups Continue to Attract Venture Backing08-12-11
Adventrx Tumbles on FDA's Rejection of Drug08-11-11
Med Device Industry Balks at IOM Advice to FDA 08-11-11
Study Finds 29 New Genetic Variants Tied to MS08-11-11
Russia Gets Innovative08-11-11
The August 2011 Issue of The Burrill Report08-11-11
Fraud and Errors Fuel Research Journal Retractions08-10-11
Two Shots Are Better Than One08-10-11
Pfizer Expands Academic Alliances in California08-08-11
Government Backs Off Pursuit of Forest CEO08-08-11
Biggest Movers for the Week Ending August 5, 201108-02-11
NICE Rejects Novartis Oral MS Drug in Draft Guidance08-04-11
New Tax Credits for Biotechs Proposed08-05-11
Celgene and Acceleron Expand Their Collaboration08-05-11
Dendreon Shares Plummet on Weak Provenge Sales08-04-11
Smoking, Eating, and Drinking Beyond Their Years08-05-11
WellDoc Rings Up Success with Diabetes Management App08-05-11
M&A Spells Disaster for R&D08-05-11
Shionogi Moves into China08-04-11
Covance CEO Sees Integration Challenges For Competition08-05-11
Doctors Say They Are Ill-Prepared for Personalized Medicine08-04-11
Dendreon Shares Plummet, Forcing Cutbacks08-04-11
Biggest Movers for the Week Ending July 29, 201108-02-11
Merck to Cut Up to 13,000 Jobs by 201507-29-11
Cloud Control07-29-11
Horizon Pharma Goes Public07-29-11
Boston Scientific Plans China Expansion07-29-11
Big Pharma's Falling R&D Investment Helps Small Biotechs07-29-11
Gene Patents Upheld in Myriad Appeal07-29-11
Different Take on Cancer Suggests Early Chance for Prevention07-29-11
Government Wins Stem Cell Victory 07-29-11
U.S. Healthcare Spending to Hit $4.6 Trillion by 202007-29-11
Getting the Prevent Defense to Pay Off07-29-11
Getting the Prevent Defense Pay Off07-29-11
Government Wins Stem Cell Victory in the Courts07-29-11
How Big Pharma's Falling R&D Investment is Helping Small Biotechs07-29-11
Can the Prevent Defense Pay Off07-29-11
Express Scripts finds a match in $29.1 Billion deal to buy Medco07-22-11
M&A in a Risk-Sharing Environment07-22-11
Merck Establishes Joint Venture with Simcere Pharmaceuticals07-22-11
Sanofi Halts Trial of Key Drug as Regulators Examine Adverse Events07-22-11
Venture Investment Surges in Life Sciences07-23-11
Study Finds Disease Modifying MS Drug Too Costly07-22-11
What I Did on My Summer Vacation 07-22-11
Halting a Brain Drain07-22-11
Defining When a Medical App is a Regulated App07-22-11
The July 2011 Issue of The Burrill Report07-20-11
Project Runway07-20-11
FDA Issues Draft Guidance on Mobile Medical Apps07-20-11
Novartis Eyes Potential Chinese IPO07-16-11
Innate Pharma Lands Major Collaboration with BMS07-08-11
Amgen Tries Micromet's BiTE07-15-11
Hot Tea and Coffee Could Fight MRSA07-14-11
Supply of Essential Medicines Falls Short in U.S. Hospitals07-15-11
FDA Delivers Blow to Transcept Over Insomnia Drug07-15-11
Astellas Bets $35M on Vical Vaccine07-15-11
FDA Wants Companion Diagnostics Approved with Paired Drugs07-15-11
Unlocking Health Trends in 140 Characters07-15-11
Expanding Personalized Medicine in Psychiatry 07-15-11
Debt Fight Snares Pharmaceutical Pricing07-14-11
TPG Capital Takes Immucor Private for $1.97B07-08-11
Innate Pharma Lands Major Collaboration with Bristol-Myers Squibb07-08-11
Blame innovation!07-08-11
Heart Failure Drug Natrecor Found To Be Ineffective07-08-11
E-prescribing Is Not Error Free07-08-11
Better Together07-07-11
Ensuring QB3 Innovation Creates Jobs07-07-11
Nearing the Home Stretch07-07-11
Vigilance Pays Off07-07-11
Study Raises Concerns About New Risks From Actos and Avandia06-27-11
Comparative Effectiveness Research Brings Industry to a Defining Moment06-30-11
Capital Flows to Massachusetts Startups07-01-11
A Billion-Dollar 06-30-11
Mutually Beneficial06-27-11
Gene Therapy Awaiting FDA Greenlight to Begin HIV Trial07-01-11
Comparative Effectiveness Researach Brings Industry to a Defining Moment06-30-11
A Billion-Dollar "No" Vote for Genentech 06-30-11
China Renews Commitment to Biotechnology06-29-11
Genentech Options Forma's Preclinical Cancer Program06-28-11
Stormy Weather06-27-11
Google Shutters Health Records Site 06-27-11
GSK to Pay $40.8 Million to Settle Case Over Puerto Rico Plant06-22-11
Tesaro Secures $101 Million in Venture Capital 06-23-11
Doing What It Takes?Or Not06-23-11
Vermont Law Blocking Prescription Data Mining Overturned06-23-11
Abbott makes $85 Million Bet on Biotest06-23-11
Analysis of FDA Data Shows Average Review Time Up06-23-11
FDA Surveys Import Risks06-23-11
Venture Capitalists Say IPO Activity Levels Too Low06-23-11
A Rare Disease Pioneer Scores $45 Million for New Company 06-23-11
Tout Tweets06-22-11
WHO Knows06-17-11
J&J Exiting Drug-Eluting Stent Market06-17-11
Merck Strikes Biosimilars Deal with Hanhwa06-17-11
Merck Strikes Biosimilars Deal with Hanwa06-17-11
Should FDA Stand for Fast Drug Approvals?06-17-11
Startup Snags Big Biotech Partner06-17-11
NIH Expands Support for Translational Research06-17-11